-
Posted by
Two Blokes May 1 -
Filed in
General
-
#TwoBlokesTrading
-
0 views
Eli Lilly (LLY) stock is sinking as investors react to concerns around GLP-1 drugs and industry dynamics. Red Brook Advisors managing partner Syed Husain joins Catalysts to discuss the market moves and explain why markets may be overreacting.
